With the market declines we have been seeing for the past several weeks, many stocks are trading well off their recent highs. It's promising to see insiders taking advantage of this recent drop by purchasing shares in some of the names below. Insider buying can be a great sign that a stock is a real value or that it is going higher in the near future. Insiders tend to know their companies better than outsiders or analysts, so when they put their own money in share purchases it can be very meaningful. I have provided links for each stock which verifies the insider buying filed with the SEC below.
Vistaprint (VPRT) shares are trading at $28.71. Vistaprint offers online printing services and products for business. The shares currently trade above the 50-day moving average of $27.75 and below the 200-day moving average of $43.45. These shares have traded in a 52 week range between $23.89 and $56.25. Earnings estimates for VPRT are about $1.61 per share and $1.95 for 2012. Vistaprint continues to take away market share from smaller companies and there is no reason why this trend won't continue to boost results in the future. An insider recently bought over 2,000 shares.
Alnylam Pharmaceuticals, Inc. (ALNY) is trading around $7.51. ALNY is a biotechnology company based in Massachusetts. These shares have traded in a range between $5.88 to $13.98 in the last 52 weeks. The 50-day moving average is $6.85 and the 200-day moving average is $9.12. ALNY is estimated to lose about $1.36 per share in 2011 and post a loss of about $1.77 per share for 2012. In the product development pipeline, Alnylam has candidates for Huntington's disease, liver cancer, RSV infections, anemia and more. The CEO recently bought 1,480 shares.
Alcoa Inc. (AA) is trading at about $10.26. Alcoa is a leading producer of aluminum products. These shares have a 52-week range of $8.45 and $18.47. The 50-day moving average is $11.23 and the 200-day moving average is $15.04, so the shares are trading well below these key support levels. Book value is stated at $13.97 per share. Earnings estimates indicate a profit of 94 cents per share for 2011 and $1.10 for 2012. AA pays a dividend of 12 cents per share which is equivalent to a 1.2% yield. A director recently bought about 2,000 shares.
Diamond Foods (DMND) is trading around $74.62. Diamond is a maker of snack products with well-known brands like Emerald nuts, Pop Secret popcorn, and more. These shares have traded in a range between $42.57 to $96.13 in the last 52 weeks. The 50-day moving average is $76.53 and the 200-day moving average is $65.52. DMND is estimated to earn about $3.15 per share in 2011, and $3.68 in 2012. DMND pays a dividend of 18 cents per share which is equivalent to a .2% yield. This stock appears overvalued and the dividend pays less than many other stocks, so I would not buy this stock, but the CFO recently bought 1,000 shares.
Neurocrine Biosciences Inc. (NBIX) shares are trading at $6.39. Neurocrine is a biotechnology company, and is based in California. These shares have traded in a range between $5.42 to $9.30 in the last 52 weeks. The 50-day moving average is $5.92 and the 200-day moving average is $7.08. Earnings estimates for NBIX are for a profit of 64 cents per share in 2011 and 6 cents for 2012. This stock recently dropped to a new 52-week low, and has rebounded. It could retest that low soon, and that might be the best time to buy. An insider recently bought over 70,000 shares.
Woodward, Inc. (WWD) shares are trading at $32.11. Woodward is a maker of industrial products such as combustion systems and is based in Colorado. These shares have traded in a range between $24.39 to $39.52 in the last 52 weeks. The 50-day moving average is $29.23 and the 200-day moving average is $32.98. Earnings estimates indicate a profit of $1.86 per share for 2011 and $2.25 for 2012. WWD pays a dividend of 28 cents per share, which is equivalent to a 0.9% yield. An insider recently bought over 3,000 shares.
Data is sourced from Yahoo Finance and Insidercow.com.
Disclaimer: The information and data is believed to be accurate, but no guarantees or representations are made. Rougemont is not a registered investment advisor and does not provide specific investment advice. The information contained herein is for informational purposes only.